Findings

What do systematic reviews say?

6 questions · 6 findings · 2 reviews

No studies found 5 · 83.3%GRADE not reported 0 · 0%Very low 1 · 16.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Adverse events · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of ulcerative colitis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adverse events · Patients with active Crohn's disease

It is very uncertain whether cannabis cigarettes (115 mg THC) changes adverse events compared with placebo cigarettes (very low certainty).

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
RR 4.09 [1.15, 14.57]
1 study · 21 participants
Very low

Serious adverse events · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of ulcerative colitis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Serious adverse events · Patients with active Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Withdrawals due to adverse events · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of ulcerative colitis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Withdrawals due to adverse events · Patients with active Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found